ASTRO Practical Radiation Oncology Program 2023: A Comprehensive Guide

This esteemed program is composed of ten enlightening sessions, delivering cutting-edge insights into the realm of radiation oncology.

Session 1: Updates in Breast Cancer

Gain expert knowledge on hypofractionation, treatment techniques, and systemic therapy for breast cancer from renowned speakers Nicolas Prionas, MD, PhD, Jolinta Lin, MD, and Cathie Chung, MD.

Session 2: The Who, What, and How of Sarcoma

Explore the world of sarcoma with Manpreet Bedi, MD, MS, Andrew Bishop, MD, and Anusha Kalbasi, MD, as they delve into the complexities of sarcoma management and treatment.

Session 3: Larynx Cancer Management

Uncover the latest strategies in larynx cancer treatment with David Sher, MD, MPH, Zain Husain, MD, and Gary Walker, MD, MS, MPH, covering early stage, locally advanced, and post-operative care.

Session 4: Updates in Lung Cancer Management

Stay ahead in lung cancer treatment with expert insights from Saumil Gandhi, MD, PhD, Uzoma Iheagwara, MD, PhD, and Sara Zakem, MD, BS, covering stage III non-small cell lung cancer and reirradiation strategies.

Session 5: Reirradiation for Prostate, CNS, and Head and Neck Cancers

Discover the latest developments in reirradiation therapy with Abhishek Solanki, MD, MS, Susan McGovern, MD, PhD, and James Caudell, MD, PhD, addressing local recurrence of prostatic carcinoma, CNS malignancy, and head and neck cancers.

Session 6: Inoperable/Recurrent Endometrial Cancer and Building a Brachytherapy Practice

Learn from the experts – J. Spencer Thompson, MD, Emma Fields, MD, and Malolan Rajagopalan, MD, MBA – as they discuss inoperable endometrial cancer, recurrent endometrial cancer, and building a successful brachytherapy program in community settings.

Session 7: Management of Primary Brain Tumors and Radiosurgery Program Development

Explore the molecular era of primary brain tumor management with Sara Hardy, MD, MS, Raju Raval, MD, DPhil, and Roshan Prabhu, MD, MS, and discover strategies for building and refining radiosurgery programs.

Session 8: Oligometastatic Disease and Practical Aspects of Metastasis-Directed Therapy

Dive into the world of oligometastatic disease with Beant Gill, MD, David Palma, MD, PhD, and Melissa O’Neil, MRT(T), as they discuss data and dose selection, prognostication, and patient selection.

Session 9: Maximizing Patient Outcomes in Gastrointestinal Cancer

Join Edward Kim, MD, Krishan Jethwa, MD, and Erqi Pollom, MD, MS, as they share their expertise on optimizing multimodality management of gastroesophageal junction cancer, rectal cancer, and pancreatic cancer.

Session 10: Personalization of Systemic Therapy for Localized to Metastatic Prostate Cancer

Conclude the program with insights from Angela Jia, MD, PhD, Anne Rajkumar, MD, and Rana Mckay, MD, as they address personalization of systemic therapy, ADT use, and combination therapies for prostate cancer patients.

This comprehensive program is designed for community practice physicians, offering disease site reviews, interactive case-based discussions, coding updates, and scientific overviews.

Target Audience

Radiation oncologists, radiation oncology residents, radiation therapists, radiation dosimetrists, medical oncologists, surgeons, physicists, nurses, pathologists, and urologists will benefit from this activity.

Learning Objectives

• Discuss various techniques for breast cancer patient set-up and motion management.
• Discuss hypofractionation and ultra-hypofractionation techniques.
• Identify the different treatment strategies for sarcoma based on clinical presentation.
• Implement different treatment techniques for sarcoma based on clinical scenario.
• Discuss treatment of larynx cancers for different stages of disease.
• Manage care of long-term survivors of larynx cancer.
• Contour planning volumes to the current standard of care in lung cancer management.
• Select appropriate dose/fractionation schedule for common palliative scenarios in lung cancer management.
• Know appropriate fractionation schemes for retreatment in the central nervous system, head and neck, and prostate.
• Understand the risk/benefit ratio of retreatment in the central nervous system, head and neck, and prostate and be able to communicate this to patients.
• Assess their existing brachytherapy capabilities for treatment of gynecologic cancers and evaluate ways to enhance access and capabilities in a community setting.
• Select patients for appropriate treatment of recurrent or inoperable endometrial cancer and navigate anatomic or technical challenges to provide quality radiation care.
• Incorporate information to improve the management of primary and metastatic brain tumors.
• Return to their teams with techniques to improve their radiosurgery programs in the treatment of primary brain tumors.
• Comfortably differentiate patients with oligometastatic disease that may benefit from radiation therapy in the context of recent supportive studies.
• Assess their available resources and apply safe, effective radiation when indicated with greater comfort of dose, technique, timing, and prognostication principles specific to metastasis-directed radiation.
• Discuss the multidisciplinary management of esophagogastric, borderline resectable pancreatic and rectal cancer.
• Optimize radiation techniques and plans for esophagogastric, borderline resectable pancreatic and rectal cancer.
• Assess updated dose limits to critical structures to minimize long-term morbidity.
• Determine what data and testing are available to tailor the use of androgen deprivation therapy in intermediate risk and post-prostatectomy patients.
• Explain the combinations and sequencing of systemic therapies for high-risk, node-positive, and metastatic prostate cancer patients.